3,704
Views
5
CrossRef citations to date
0
Altmetric
Research Articles

Aerosol release, distribution, and prevention during aerosol therapy: a simulated model for infection control

, , &
Pages 10-17 | Received 27 Oct 2021, Accepted 29 Nov 2021, Published online: 28 Dec 2021

References

  • Acosta MAT, Singer BD. (2020). Pathogenesis of COVID-19-induced ARDS: implications for an aging population. Eur Respir J 56:2002049.
  • Agarwal A, Basmaji J, Muttalib F, et al. (2020). High-flow nasal cannula for acute hypoxemic respiratory failure in patients with COVID-19: systematic reviews of effectiveness and its risks of aerosolization, dispersion, and infection transmission. Can J Anaesth 67:1217–48.
  • Ari A, Fink JB, Pilbeam SP. (2016). Secondhand aerosol exposure during mechanical ventilation with and without expiratory filters: an in-vitro study. Indian J Respir Care 5:677–82.
  • Badraoui R, Alrashedi MM, Bardakci F. (2020). Acute respiratory distress syndrome: a life threatening associated complication of SARS-CoV-2 infection inducing COVID-19. J Biomol Struct Dyn 39:6842–51.
  • Bennett G, Joyce M, Fernández EF, MacLoughlin R. (2019). Comparison of aerosol delivery across combinations of drug delivery interfaces with and without concurrent high-flow nasal therapy. Intensive Care Med Exp 7:20.
  • Bennett G, Joyce M, Sweeney L, MacLoughlin R. (2018). In vitro determination of the main effects in the design of high-flow nasal therapy systems with respect to aerosol performance. Pulm Ther 4:73–86.
  • Bennett G, Joyce M, Sweeney L, MacLoughlin R. (2019). In vitro study of the effect of breathing pattern on aerosol delivery during high-flow nasal therapy. Pulm Ther 5:43–54.
  • Bhashyam AR, Wolf MT, Marcinkowski AL, et al. (2008). Aerosol delivery through nasal cannulas: an in vitro study. J Aerosol Med Pulm Drug Deliv 21:181–8.
  • Ciuzas D, Prasauskas T, Krugly E, et al. (2015). Characterization of indoor aerosol temporal variations for the real-time management of indoor air quality. Atmos Environ 118:107–17.
  • Cortegiani A, Accurso G, Mercadante S, et al. (2018). High flow nasal therapy in perioperative medicine: from operating room to general ward. BMC Anesthesiol 18:8.
  • Dailey PA, Harwood R, Walsh K, et al. (2017). Aerosol delivery through adult high flow nasal cannula with heliox and oxygen. Respir Care 62:1186–92.
  • Fernández Fernández E, Joyce M, O’Sullivan A, Macloughlin R. (2021). Evaluation of aerosol therapy during the escalation of care in a model of adult cystic fibrosis. Antibiotics 10:472.
  • Hui DS, Chow BK, Chu LCY, et al. (2009). Exhaled air and aerosolized droplet dispersion during application of a jet nebulizer. Chest 135:648–54.
  • Hui DS, Chow BK, Lo T, et al. (2015). Exhaled air dispersion during noninvasive ventilation via helmets and a total facemask. Chest 147:1336–43.
  • Hui DS, Hall SD, Chan MTV, et al. (2007). Exhaled air dispersion during oxygen delivery via a simple oxygen mask. Chest 132:540–6.
  • Hunter JC, Nguyen D, Aden B, et al. (2016). Transmission of Middle East Respiratory Syndrome coronavirus infections in healthcare settings, Abu Dhabi. Emerg Infect Dis 22:647–56.
  • ISO. (2013). ISO 27427:2013 – anaesthetic and respiratory equipment — nebulizing systems and components, (Geneva, ISO; US Pharmacopoeia).
  • Jackson T, Deibert D, Wyatt G, et al. (2020). Classification of aerosol-generating procedures: a rapid systematic review. BMJ Open Respir Res 7:1–9.
  • Joyce M, McGrath JA, Mac Giolla Eain M, et al. (2021). Nebuliser type influences both patient-derived bioaerosol emissions and ventilation parameters during mechanical ventilation. Pharmaceutics 13:199.
  • Li Q, Guan X, Wu P, et al. (2020). Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med 382:1199–207.
  • Liu Y, Ning Z, Chen Y, et al. (2020). Aerodynamic analysis of SARS-CoV-2 in two Wuhan hospitals. Nature 582:557–60.
  • Loeb M, McGeer A, Henry B, et al. (2004). SARS among critical care nurses, Toronto. Emerg Infect Dis 10:251–5.
  • Long CM, Suh HH, Catalano PJ, Koutrakis P. (2001). Using time- and size-resolved particulate data to quantify indoor penetration and deposition behavior. Environ Sci Technol 35:2089–99.
  • Mac Giolla Eain M, Joyce M, O’Sullivan A, et al. (2021). An in vitro investigation into the release of fugitive medical aerosols into the environment during manual ventilation. J Hosp Infect 108:135–41.
  • Malik Peiris JS, Poon LLM, Guan Y. (2009). Emergence of a novel swine-origin influenza A virus (S-OIV) H1N1 virus in humans. J Clin Virol 45:169–73.
  • McGrath JA, O’Sullivan A, Bennett G, et al. (2019a). Investigation of the quantity of exhaled aerosols released into the environment during nebulisation. Pharmaceutics 11:75.
  • McGrath JA, O’Toole C, Bennett G, et al. (2019b). Investigation of fugitive aerosols released into the environment during high-flow therapy. Pharmaceutics 11:254.
  • O’Neil CA, Li J, Leavey A, et al. (2017). Characterization of aerosols generated during patient care activities. Clin Infect Dis 65:1342–8.
  • Ong SWX, Tan YK, Chia PY, et al. (2020). Air, surface environmental, and personal protective equipment contamination by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from a symptomatic patient. JAMA 323:1610–2.
  • Réminiac F, Vecellio L, Heuzé-Vourc’h N, et al. (2016). Aerosol therapy in adults receiving high flow nasal cannula oxygen therapy. J Aerosol Med Pulm Drug Deliv 29:134–41.
  • Rygg A, Longest PW. (2016). Absorption and clearance of pharmaceutical aerosols in the human nose: development of a CFD model. J Aerosol Med Pulm Drug Deliv 29:416–31.
  • Saeed H, Harb HS, Madney YM, Abdelrahim MEA. (2021). Aerosol delivery via noninvasive ventilation: role of models and bioanalysis. Ann Transl Med 9:589.
  • Settles GS. (2001). Schlieren and shadowgraph techniques: visualizing phenomena in transparent media. Springer Science Business Media (Berlin, Germany).
  • Sherman M. (1992). Simplified modeling for infiltration and radon entry. Thermal Performance of the Exterior Envelopes of Buildings Conference; Clearwater Beach, FL.
  • Sim ES, Dharmarajan H, Sai D, et al. (2021). Novel use of vitamin B2 as a fluorescent tracer in aerosol and droplet contamination models in otolaryngology. Ann Otol Rhinol Laryngol 130:280–5.
  • Simonds AK, Hanak A, Chatwin M, et al. (2010). Evaluation of droplet dispersion during non-invasive ventilation, oxygen therapy, nebuliser treatment and chest physiotherapy in clinical practice: implications for management of pandemic influenza and other airborne infections. Health Technol Assess 14:131–72.
  • Takazono T, Yamamoto K, Okamoto R, et al. (2021). Effects of surgical masks on droplet dispersion under various oxygen delivery modalities. Crit Care 25:4.
  • Tang JW, Liebner TJ, Craven BA, Settles GS. (2009). A Schlieren optical study of the human cough with and without wearing masks for aerosol infection control. J R Soc Interface 6:727–36.
  • Thielicke W, Stamhuis EJ. (2014). PIVlab – towards user-friendly, affordable and accurate digital particle image velocimetry in Matlab. J Open Res Softw 2.
  • Tran K, Cimon K, Severn M, et al. (2012). Aerosol generating procedures and risk of transmission of acute respiratory infections to healthcare workers: a systematic review. PLOS One 7:e35797.
  • van Doremalen N, Bushmaker T, Morris DH, et al. (2020). Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. N Engl J Med 382:1564–7.
  • WHO. (1730). A multicentre collaboration to investigate the cause of severe acute respiratory syndrome. Lancet 361:3.
  • WHO. (2014). Infection prevention and control of epidemic- and pandemic-prone acute respiratory infections in health care. Available at: http://apps.who.int/iris/bitstream/handle/10665/112656/9789241507134_eng.pdf [last accessed 20 Aug 2021].
  • Wittgen BPH, Kunst PWA, Perkins WR, et al. (2006). Assessing a system to capture stray aerosol during inhalation of nebulized liposomal cisplatin. J Aerosol Med 19:385–91.
  • Xi J, Kim J, Si XA. (2014). Effects of nostril orientation on airflow dynamics, heat exchange, and particle depositions in human noses. Eur J Mech B Fluids 6:567–77.
  • Zumla A, Hui DS, Perlman S. (2015). Middle East Respiratory Syndrome. Lancet 386:995–1007.